Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial
Author:
Affiliation:
1. TIMI Study Group, Cardiovascular Division, Department of Medicine; Brigham and Women's Hospital, and Harvard Medical School; Boston Massachusetts
2. Gilead Science, Inc.; Foster City California
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference19 articles.
1. Heart disease and stroke statistics-2013 update: a report from the American Heart Association;Go;Circulation.,2013
2. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization;Kones;Vasc Health Risk Manag,2010
3. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Anderson;J Am Coll Cardiol.,2013
4. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions;Chaitman;Circulation.,2006
5. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina;Chaitman;J Am Coll Cardiol.,2004
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Rationale and Design of the KOSovan Acute Coronary Syndrome (KOS-ACS) Registry;Diagnostics;2024-07-11
2. Current ideas about the role of ranolazine in patients’ treatment with angina pectoris;Meditsinskiy sovet = Medical Council;2024-01-18
3. Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention;Medicina;2024-01-16
4. Anti-ischemic and pleiotropic effects of ranolazine in chronic coronary syndromes;The American Journal of the Medical Sciences;2023-12
5. Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review;Journal of Cardiovascular Pharmacology;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3